Related Experiment Videos
Replying to Veatch's concerns: special moral problems with total artificial heart inactivation
1Monash University, East Bentleigh, Victoria, Australia and Loma Linda University, Loma Linda, CA, USA. Bioethics@go.com
Death Studies
|May 17, 2003
Summary
Inactivating total artificial heart technology raises moral questions, but it is not ethically required to remove the device during therapy withdrawal. This decision requires shared decision-making among the patient, medical team, and ethics committee.
Area of Science:
- Medical Ethics
- Cardiovascular Surgery
- Bioethics
Background:
- Total artificial heart (TAH) technology presents unique ethical challenges regarding device inactivation.
- Current ethical frameworks do not mandate explantation of TAH devices during therapy withdrawal.
Discussion:
- Inactivating a TAH device is ethically distinct from active euthanasia or patient killing.
- Clinical and ethical justification is necessary before considering TAH inactivation.
- Physician autonomy in TAH inactivation decisions is limited; shared decision-making is crucial.
Key Insights:
- There is no ethical obligation to explant a TAH as part of therapy withdrawal.
- TAH inactivation is not morally equivalent to active killing.
- Shared decision-making involving patients, surrogates, and medical teams is essential for TAH inactivation.
Outlook:
- Further ethical discourse is needed to refine guidelines for TAH management.
- Legal and ethics committee consultations are recommended for complex cases.
- This analysis supports ethical TAH inactivation when clinically indicated, emphasizing patient-centered care.
Keywords:
Death and Euthanasia